When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Open-angle glaucoma

Last reviewed: 24 Oct 2024
Last updated: 20 Nov 2024

Summary

Definition

History and exam

Key diagnostic factors

  • presence of risk factors
  • cup-to-disc ratio >0.5
  • notching of optic nerve cup
  • symptomatic peripheral vision loss
  • increased intra-ocular pressure
  • scotomas
  • loss of nerve fibre layer
  • optic disc haemorrhage
Full details

Other diagnostic factors

  • corneal hysteresis
Full details

Risk factors

  • intra-ocular pressure >21 mmHg
  • age >50 years
  • family history of glaucoma
  • genetic abnormalities
  • black ethnicity or Hispanic ethnicity
  • myopia
  • diabetes mellitus
  • hypertension
  • low ocular perfusion pressure
  • thin central corneal thickness
  • corneal hysteresis
  • calcium-channel blockers
Full details

Diagnostic investigations

1st investigations to order

  • tonometry
  • gonioscopy
  • direct ophthalmoscopy
  • indirect ophthalmoscopy
  • slit-lamp biomicroscopy
  • visual field testing
  • optical coherence tomography scanning
Full details

Investigations to consider

  • digital imaging
  • pachymetry
  • nerve fibre layer analysis
Full details

Emerging tests

  • corneal hysteresis

Treatment algorithm

ACUTE

eye drops preferred or laser trabeculoplasty contraindicated/failed

laser trabeculoplasty preferred or eye drops contraindicated /failed

eye drops contraindicated /failed and rapidly progressive disease

ONGOING

treatment failure

Contributors

Authors

Nishani Amerasinghe, MBBS, BSc(Hons), FRCOphth

Consultant Ophthalmic Surgeon

Glaucoma Specialist

University Hospital Southampton NHS Trust

Southampton

UK

Disclosures

NA is president-elect of the UK and Éire Glaucoma Society and has acted as an unpaid advisor to NICE and The Royal College of Ophthalmologists. NA has served on an advisory panel for Santen and has received travel honoraria and speaker's fees from Thea Pharmaceuticals, Santen, and Allergan. NA has received research funding from AbbVie Pharmaceuticals.

Irena Serov-Volach, MD

Senior Glaucoma and Cataract Fellow

Ophthalmology department

Eye Unit

Epsom and St Helier University Hospitals NHS Trust

London

UK

Disclosures

ISV has received consultancy/travel fees from Glaukos.

Acknowledgements

Dr Nishani Amerasinghe and Dr Irena Serov-Volach would like to gratefully acknowledge Dr Robert B. Avery and Dr Michael N. Wiggins, the previous contributors to this topic.

Disclosures

RBA and MNW declare that they have no competing interests.

Peer reviewers

Andrew Chen, MD

Assistant Professor

University of Washington

Seattle

WA

Disclosures

AC declares that he has received research funding from Janssen LLC.

Sheila Sanders, MD

​Professor of Ophthalmology

University of Kentucky

South Limestone

Lexington

KY

Disclosures

SS declares that she has no competing interests.

Mohamed Khodeiry, MD

Glaucoma Fellow

University of Kentucky

South Limestone

Lexington

KY

Disclosures

MK declares that he has no competing interests.

Roshini Sanders, FRCS, FRCOphth

Consultant Ophthalmologist

Queen Margaret Hospital

Dunfermline

Fife

UK

Disclosures

RS declares that she has no competing interests.

  • Open-angle glaucoma images
  • Differentials

    • Normal-tension glaucoma
    • Angle-closure glaucoma
    • High myopia
    More Differentials
  • Guidelines

    • Glaucoma summary benchmarks - 2023
    • Trabeculectomy with a biodegradable collagen matrix implant for glaucoma
    More Guidelines
  • Patient information

    Glaucoma

    More Patient information
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer